As we all know, miR-7 is able to inhibit tumor growth and metastasis by targetting the phosphoinositide 3-kinase/Akt (PI3k/AKT) pathway in hepatocellular carcinoma (HCC) [55]. This evidence concerns the gene AKT1 and hepatocellular carcinoma.